MedPacto메드팩토
235980 · KOSDAQ · ₩235980 · 메드팩토
₩3,050▲ ₩80 (2.69%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩3.9B | ₩0 | ₩0 | ₩0 | ₩0 |
| Cost of sales | ₩3.5B | ₩0 | ₩0 | ₩0 | ₩0 |
| Gross profit | ₩385M | ₩0 | ₩0 | ₩0 | ₩0 |
| Operating income | −₩14B | −₩22B | −₩29B | −₩37B | −₩29B |
| Net income | −₩13B | −₩20B | −₩35B | −₩36B | −₩17B |
| Net income to shareholders | −₩13B | −₩20B | −₩35B | −₩36B | −₩17B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩49B | ₩61B | ₩80B | ₩108B | ₩133B |
| Current assets | ₩45B | ₩57B | ₩75B | ₩100B | ₩126B |
| Cash and equivalents | ₩12B | ₩15B | ₩73B | ₩360M | ₩1.3B |
| Total liabilities | ₩2.7B | ₩3B | ₩9.6B | ₩75B | ₩90B |
| Current liabilities | ₩1.4B | ₩1.4B | ₩7.7B | ₩73B | ₩978M |
| Borrowings | ₩1.7B | ₩1.5B | ₩1.7B | ₩2.4B | ₩75B |
| Total equity | ₩46B | ₩58B | ₩71B | ₩32B | ₩44B |
| Shareholders' equity | ₩46B | ₩58B | ₩71B | ₩32B | ₩44B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩13B | −₩17B | −₩26B | −₩30B | −₩25B |
| Capital spending | ₩91M | ₩314M | ₩101M | ₩878M | ₩757M |
| Free cash flow | −₩13B | −₩17B | −₩26B | −₩30B | −₩26B |
Consolidated where available. Amounts in won.
Also known as: MedPacto / 메드팩토 / 235980 / KRX:235980
Source: KRX statistical information